A more targeted approach when treating pig diseases is in line with the
sector-wide strategy to promote safe pork for consumers. In recent years the
pharmaceutical industry has contributed to this commitment with the introduction
of the single shot therapy. A new series in Pig Progress is going to investigate
the science behind the single shot and make an assessment of the pros and cons
for veterinarians and producers. But first, a Danish veterinary consultant
outlines on-farm opportunities aiming to limit the level of unnecessary
treatments against disease.
This article can also be found in Pig
Progress magazine Volume 22 number 7. To view this article on-line simply click
on the pdf link below.
To comment, login here
Or register to be able to comment.